USPH Stock Analysis: Buy, Sell, or Hold?
USPH - US Physical Therapy Inc
$72.35
1.04 (1.46%)
▲
5d:
+9.09%
30d:
+15.76%
90d:
-2.76%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When USPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: USPH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: USPH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$130.70
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$81.15
10.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: USPH is currently trading at $72.35, which is considered extended relative to its 30-day fair value range of $61.90 to $67.76. The stock's valuation (Forward PE: 21.2) is in line with its historical norms (23.5). Remarkably, the market is currently pricing in an annual earnings decline of 3.4% over the next few years. This pessimistic expectation contrasts with the company's recent 23.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, USPH is in a strong downtrend. The price is approaching resistance at $65.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: USPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $93.67 (+29.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, USPH is in a strong downtrend. The price is approaching resistance at $65.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: USPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $93.67 (+29.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$61.90 -
$67.76
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range (+6.8% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.5% below Wall St target ($93.67)
Trading Range Analysis
30-Day Trading Range
$61.90 -
$67.76
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$61.06
Resistance Level
$65.29
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.20
Wall Street Target
$93.67
(+29.5%)
Revenue Growth (YoY)
7.9%
Earnings Growth (YoY)
23.6%
Profit Margin
4.4%
Valuation Discount vs History
-3.4% cheaper
PE vs Historical
21.2 vs 23.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.4%
(market-implied from PE analysis)
1-Year Target
$69.89
(-3%)
2-Year Target
$67.51
(-7%)
3-Year Target
$65.22
(-10%)
3-Yr Target (if PE normalizes)
(PE: 21→24)
$72.30
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 16.7%)
$118.07
(+63%)
Base:
(SPY PE: 21.2, Growth: 16.7%)
$114.91
(+59%)
Bear:
(PE: 18.0, Growth: 16.7%)
$97.68
(+35%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Forward PE: 25.00 | Forward EPS (Implied): $2.89
Bull Case
$87.36
(+21%)
Analyst growth 15.0%, PE expands to 26.3
Base Case
$72.35
(0%)
Market implied 0.0%, PE stable at 25.0
Bear Case
$55.35
(-24%)
Severe decline -15.0%, PE contracts to 22.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.2 to 23.5
Stabilization Target:
$80.21
(+10.9%)
PE Expansion Potential:
+10.9%
Share & Embed Analysis
Last updated: July 04, 2026 4:13 AM ET
Data refreshes hourly during market hours. Next update: 5:13 AM
Data refreshes hourly during market hours. Next update: 5:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is USPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Graham D Reeve
SELL
662 shares
2026-03-11
Richard Binstein
SELL
3000 shares
2026-03-06
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$243 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$500 | 66 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 BUY |
